This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "hemolytic_anemia_erythrocyte_destruction#Premature Erythrocyte Destruction"). The module defines the expected pathophysiology structure; conforming nodes in disorder files should include the corresponding cell types, biological processes, and causal edges, specialized to their primary lesion. Key disorder-specific substitutions: hereditary spherocytosis substitutes a defective membrane/cytoskeletal protein (ankyrin-1, band 3, spectrin) at the trigger node; G6PD and pyruvate kinase deficiency substitute the deficient enzyme; sickle cell disease and thalassemia substitute the abnormal hemoglobin and add ineffective erythropoiesis; autoimmune hemolytic anemia substitutes anti-erythrocyte autoantibody and complement at the trigger and central-effector nodes. The generic effector cell at the destruction node is the macrophage (CL:0000235), representing the splenic red-pulp macrophage that performs erythrophagocytosis.
Reduced Erythrocyte Integrity
trigger
The cascade is initiated by an intrinsic red blood cell defect (membrane or cytoskeletal protein abnormality, enzyme deficiency, or abnormal hemoglobin) or by an extrinsic antibody-mediated, complement-mediated, or mechanical insult. The nature of the lesion varies by disorder, but each compromises erythrocyte integrity and deformability and renders the cell vulnerable to premature removal from the circulation.
Downstream
-
Oxidative and Membrane Injury
Oxidative and Membrane Injury
amplifier
The primary lesion is amplified by oxidative damage and progressive injury to the erythrocyte membrane and cytoskeleton. Reactive oxygen species, impaired antioxidant defenses, hemoglobin denaturation (Heinz bodies), and loss of membrane surface area reduce deformability and expose removal signals such as phosphatidylserine, marking the cell for clearance.
Downstream
-
Premature Erythrocyte Destruction
Premature Erythrocyte Destruction
central effector
Damaged, poorly deformable, or antibody/complement-opsonized erythrocytes are destroyed prematurely. Extravascularly, splenic red-pulp macrophages recognize removal signals (phosphatidylserine exposure, bound immunoglobulin, or complement opsonins) and perform erythrophagocytosis; intravascularly, complement-mediated lysis or mechanical fragmentation destroys cells within the circulation. This is the central effector step shared across hereditary and acquired hemolytic anemias.
Downstream
-
Shortened Erythrocyte Lifespan and Erythropoietic Strain
Shortened Erythrocyte Lifespan and Erythropoietic Strain
effector
Accelerated destruction shortens the erythrocyte lifespan and releases hemoglobin and its breakdown products (unconjugated bilirubin). The bone marrow responds with compensatory erythropoiesis and reticulocytosis, but in severe disease, or where erythropoiesis is itself ineffective (as in thalassemia), production cannot keep pace with loss, so red cell mass falls.
Hemolytic Anemia
consequence
When the rate of erythrocyte destruction exceeds the rate of compensatory production, red cell mass and hemoglobin fall, producing anemia. The hemolytic state is clinically recognized by anemia together with reticulocytosis, jaundice from increased unconjugated bilirubin, and often splenomegaly. This is the convergent disease-like phenotype (HP:0001878, MONDO:0002280) shared across all conforming disorders.